877151-43-4 Usage
Uses
Used in Pharmaceutical Industry:
2-Cyano-4-fluoro-6-Methyl-benzoic acid Methyl ester serves as a crucial intermediate in the development of pharmaceuticals. Its unique structure allows for the creation of new drugs with specific therapeutic properties, making it an essential component in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Cyano-4-fluoro-6-Methyl-benzoic acid Methyl ester is utilized as a building block for the synthesis of pesticides and other agricultural chemicals. Its incorporation into these products can enhance their effectiveness and selectivity, contributing to more efficient and sustainable agricultural practices.
Used in Materials Science:
2-Cyano-4-fluoro-6-Methyl-benzoic acid Methyl ester also finds applications in the field of materials science, where it can be used to develop new materials with improved properties. Its versatility in chemical reactions enables the creation of materials with tailored characteristics for specific applications.
Safety Precautions:
Given the nature of 2-Cyano-4-fluoro-6-Methyl-benzoic acid Methyl ester as a chemical intermediate, it is imperative to handle 2-Cyano-4-fluoro-6-Methyl-benzoic acid Methyl ester with care. Adhering to proper safety protocols is essential when working with it in laboratory or industrial settings to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 877151-43-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,7,1,5 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 877151-43:
(8*8)+(7*7)+(6*7)+(5*1)+(4*5)+(3*1)+(2*4)+(1*3)=194
194 % 10 = 4
So 877151-43-4 is a valid CAS Registry Number.
877151-43-4Relevant academic research and scientific papers
4-CARBOXAMIDO-ISOINDOLINONE DERIVATIVES AS SELECTIVE PARP-1 INHIBITORS
-
, (2014/05/24)
There are provided substituted 4-carboxamido-isoindolinone derivatives which selectively inhibit the activity of poly (ADP-ribose) polymerase PARP-1 with respect to poly (ADP-ribose) polymerase PARP-2. The compounds of this invention are therefore useful in treating diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds
